Emblem (CVE:EMC) Stock Jumps 1.6% – Should You Buy?

Emblem Corp (CVE:EMC – Get Free Report)’s stock price traded up 1.6% on Friday. The company traded as high as $1.88 and last traded at $1.88. 597,714 shares were traded during mid-day trading, a decline of 31% from the average daily volume of 865,800 shares. The stock had previously closed at $1.85.

Emblem Trading Up 1.6%

The company’s 50-day moving average is $1.88 and its 200-day moving average is $1.88. The company has a debt-to-equity ratio of 30.01, a quick ratio of 3.24 and a current ratio of 3.61. The firm has a market cap of $245.45 million and a price-to-earnings ratio of -9.89.

About Emblem

(Get Free Report)

Emblem Corp. produces, distributes, and sells medical cannabis and cannabis derivatives in Canada. The company also operates medical cannabis education centers to provide education services for making informed decisions about medical cannabis treatment options to physicians and patients. In addition, it provides various accessories. Emblem Corp. has a strategic partnership with GreenSpace Brands to develop and commercialize cannabidiol infused health and beauty products. The company is headquartered in Toronto, Canada.

See Also

Receive News & Ratings for Emblem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emblem and related companies with MarketBeat.com's FREE daily email newsletter.